Medicare Group Opposes Carveout For Drug Patents
A Medicare lobbying group has urged lawmakers not to exempt drug patents from America Invents Act proceedings, arguing that it would further undermine the stability of the Medicare and Medicaid programs....To view the full article, register now.
Already a subscriber? Click here to view full article